Learn More
Medchemexpress LLC OAB-14 | 2140911-49-3 | 99.2% | 518.73 | 1 ML

Supplier: Medchemexpress LLC HY13997310MM/1ML
OAB-14 is a derivative of Bexarotene that improves Alzheimer's disease-related pathologies and cognitive impairments. It works by increasing β-amyloid clearance and ameliorating the dysfunction of the endosomal-autophagic-lysosomal pathway in APP/PS1 transgenic mice. OAB-14 has no significant effect on body weight or liver toxicity after acute and chronic treatment.
- Improves Alzheimer's disease-related pathologies and cognitive impairments
- Increases β-amyloid clearance
- Ameliorates dysfunction of the endosomal-autophagic-lysosomal pathway
- Promotes microglia phagocytosis
- Attenuates downstream pathological events of Aβ accumulation
- Restores autophagy flux via the AMPK/mTOR pathway
- Enhances lysosomal activity and reduces Aβ accumulation in lysosomes
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.